8-(3-(3',6'-DIhydroxy-3-oxo-3h-spiro[isobenzofuran-1,9'-xanthen]-5-yl)thioureido)octanoic acid

Catalog No.: 
ACIZDR916
CAS No.: 
171263-01-7
Molecular Formula: 
C29H28N2O7S
Molecular Weight: 
548.62
8-(3-(3',6'-DIhydroxy-3-oxo-3h-spiro[isobenzofuran-1,9'-xanthen]-5-yl)thioureido)octanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$1072.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name8-(3-(3',6'-DIhydroxy-3-oxo-3h-spiro[isobenzofuran-1,9'-xanthen]-5-yl)thioureido)octanoic acid
IUPAC Name8-(3-(3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthen]-5-yl)thioureido)octanoic acid
MDL No.MFCD29090729
Molecular FormulaC29H28N2O7S
Molecular Weight548.62
SMILESOC(CCCCCCCNC(NC1=CC2=C(C3(C4=C(C=C(C=C4)O)OC5=C3C=CC(O)=C5)OC2=O)C=C1)=S)=O
InChI KeyUMKSBNGFOOPQCJ-UHFFFAOYSA-N
SynonymOctanoic acid, 8-[[[(3',6'-dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthen]-5-yl)amino]thioxomethyl]amino]-;8-(3-(3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthen]-5-yl)thioureido)octanoic acid
CAS No.171263-01-7

Synthetic Route by SureRoute

1. ACIZDR916 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDZST570 route compound structure diagram
    ACDZST5703326-34-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIZDR916 route product structure diagram
    ACIZDR916171263-01-7
Inquiry

2. ACIZDR916 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIZDR916 route product structure diagram
    ACIZDR916171263-01-7
Inquiry

3. ACIZDR916 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIZDR916 route product structure diagram
    ACIZDR916171263-01-7
Inquiry

Comments (0)